| Dr Thomas Francis Walsh, MD | |
|
100 Peach St Ste 102, Erie, PA 16507-1423 | |
| (814) 877-5700 | |
| (814) 877-5655 |
| Full Name | Dr Thomas Francis Walsh |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 42 Years |
| Location | 100 Peach St Ste 102, Erie, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255325775 | NPI | - | NPPES |
| 000000537030 | Other | OH | ANTHEM |
| 2697809 | Medicaid | OH | |
| 0982776 | Medicaid | PA | |
| 7263676 | Other | AETNA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | 35088817 (Ohio) | Secondary |
| 208800000X | Urology | MD039336L (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ashtabula County Medical Center | Ashtabula, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ashtabula County Medical Center | 2668465600 | 64 |
News Archive
Calithera Biosciences, a company developing novel oncology therapeutics, today announced the completion of a Series A financing totaling $40 million. Morgenthaler Ventures led the financing with U.S. Venture Partners, Advanced Technology Ventures, Delphi Ventures and Mission Bay Capital also participating in the round. The capital will be used to support the company's pioneering efforts to develop activators of caspases, the proteases that promote apoptotic cell death, for the treatment of cancer and other proliferative diseases.
I may get Alzheimer's disease, I was told after getting my DNA analyzed. I could suffer the consequences of an abnormal blood clot in my heart or my brain. Or perhaps I'll suffer from a disease called primary myelofibrosis that's caused by an overactive bone marrow. All of these were possible outcomes, based on my genetic profile. In each case, the test only gives an increased risk for disease, not a definitive diagnosis.
A new study presented at ANESTHESIOLOGY 2011 focused on whether blood type affects survival after heart surgery. Researchers from Duke University Medical Center studied more than 15,000 patients to determine if a specific blood type puts patients at a higher risk for death or complications after coronary artery bypass graft (CABG) surgery.
Sigma-AldrichCorporation, a leading Life Science and Technology company, announced today it signed an exclusive global distribution agreement with Roche. The agreement pairs Roche's high-quality Biochemical Reagents product portfolio with the industry-leading eCommerce and supply chain capabilities of Sigma-Aldrich.
Dementia is now the latest scare factor to be added to an ever growing list of threats which so far includes diabetes, heart disease and stroke, which obese people are apparently more prone to.
› Verified 7 days ago
| Entity Name | Ashtabula County Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942247143 PECOS PAC ID: 2668465600 Enrollment ID: O20040406000897 |
News Archive
Calithera Biosciences, a company developing novel oncology therapeutics, today announced the completion of a Series A financing totaling $40 million. Morgenthaler Ventures led the financing with U.S. Venture Partners, Advanced Technology Ventures, Delphi Ventures and Mission Bay Capital also participating in the round. The capital will be used to support the company's pioneering efforts to develop activators of caspases, the proteases that promote apoptotic cell death, for the treatment of cancer and other proliferative diseases.
I may get Alzheimer's disease, I was told after getting my DNA analyzed. I could suffer the consequences of an abnormal blood clot in my heart or my brain. Or perhaps I'll suffer from a disease called primary myelofibrosis that's caused by an overactive bone marrow. All of these were possible outcomes, based on my genetic profile. In each case, the test only gives an increased risk for disease, not a definitive diagnosis.
A new study presented at ANESTHESIOLOGY 2011 focused on whether blood type affects survival after heart surgery. Researchers from Duke University Medical Center studied more than 15,000 patients to determine if a specific blood type puts patients at a higher risk for death or complications after coronary artery bypass graft (CABG) surgery.
Sigma-AldrichCorporation, a leading Life Science and Technology company, announced today it signed an exclusive global distribution agreement with Roche. The agreement pairs Roche's high-quality Biochemical Reagents product portfolio with the industry-leading eCommerce and supply chain capabilities of Sigma-Aldrich.
Dementia is now the latest scare factor to be added to an ever growing list of threats which so far includes diabetes, heart disease and stroke, which obese people are apparently more prone to.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Thomas Francis Walsh, MD 333 State St Ste 103, Erie, PA 16507-1450 Ph: (814) 877-7157 | Dr Thomas Francis Walsh, MD 100 Peach St Ste 102, Erie, PA 16507-1423 Ph: (814) 877-5700 |
News Archive
Calithera Biosciences, a company developing novel oncology therapeutics, today announced the completion of a Series A financing totaling $40 million. Morgenthaler Ventures led the financing with U.S. Venture Partners, Advanced Technology Ventures, Delphi Ventures and Mission Bay Capital also participating in the round. The capital will be used to support the company's pioneering efforts to develop activators of caspases, the proteases that promote apoptotic cell death, for the treatment of cancer and other proliferative diseases.
I may get Alzheimer's disease, I was told after getting my DNA analyzed. I could suffer the consequences of an abnormal blood clot in my heart or my brain. Or perhaps I'll suffer from a disease called primary myelofibrosis that's caused by an overactive bone marrow. All of these were possible outcomes, based on my genetic profile. In each case, the test only gives an increased risk for disease, not a definitive diagnosis.
A new study presented at ANESTHESIOLOGY 2011 focused on whether blood type affects survival after heart surgery. Researchers from Duke University Medical Center studied more than 15,000 patients to determine if a specific blood type puts patients at a higher risk for death or complications after coronary artery bypass graft (CABG) surgery.
Sigma-AldrichCorporation, a leading Life Science and Technology company, announced today it signed an exclusive global distribution agreement with Roche. The agreement pairs Roche's high-quality Biochemical Reagents product portfolio with the industry-leading eCommerce and supply chain capabilities of Sigma-Aldrich.
Dementia is now the latest scare factor to be added to an ever growing list of threats which so far includes diabetes, heart disease and stroke, which obese people are apparently more prone to.
› Verified 7 days ago
Lori Mae Dulabon, DO Urology Medicare: Accepting Medicare Assignments Practice Location: 5401 Peach St Ste 3600, Erie, PA 16509 Phone: 814-868-2170 Fax: 814-868-2108 | |
Dr. Ankur Malpani, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 311 W 24th St Ste 101, Erie, PA 16502 Phone: 814-452-4214 Fax: 814-459-7823 | |
Justine Schober, Urology Medicare: Accepting Medicare Assignments Practice Location: 300 State St Ste 301b, Erie, PA 16507 Phone: 814-877-5700 | |
Dr. Daniel T Wendel, D.O. Urology Medicare: Not Enrolled in Medicare Practice Location: 5473 Village Common Dr, Suite 201, Erie, PA 16506 Phone: 814-833-3223 Fax: 814-833-5763 | |
Michael Miller, Urology Medicare: Accepting Medicare Assignments Practice Location: 100 Peach St Ste 102, Suite 102, Erie, PA 16507 Phone: 814-877-5700 | |
Zdzislaw J Chorazy, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 311 West 24th Street, Suite 101, Erie, PA 16502 Phone: 814-452-4214 Fax: 814-461-8424 |